 |
 |

Multiminicore Myopathy, Central Core Disease, Malignant Hyperthermia Susceptibility, and RYR1 Mutations
One Disease With Many Faces?
Arch Neurol. 2004;61:27-29.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
In this issue of ARCHIVES, Guis et al1 describe a family with autosomal dominant susceptibility to malignant hyperthermia (MH) and muscle histologic characteristics showing multiminicores in the absence of symptoms of weakness or myopathy. There was high concordance in this family among in vitro sensitivity to caffeine and halothane, multiminicores, and novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene. This family illustrates the overlap of these diseases (Table 1) and again demonstrates the power of genetic analysis to either clarify or confuse the boundaries between clinical phenotypes. It also illustrates the potential complexity of this group of diseases in which the "genetic environment" of polymorphisms is critical to the phenotype.
Table appears in full text version.
|
|
|
|
Table. Summary of Central Core Disease, Multiminicore Disease, Malignant Hyperthermia Susceptibility, and an Autosomal-Dominant Multiminicore Family
|
|
|
MH SUSCEPTIBILITY
Malignant hyperthermia susceptibility (MHS) is a genetically heterogeneous susceptibility to life-threatening rigidity, fever, and rhabdomyolysis that is provoked . . . [Full Text of this Article] CENTRAL CORE DISEASE
MULTIMINICORE DISEASE
Katherine D. Mathews, MD
Departments of Pediatrics and Neurology 2503 JCP 200 Hawkins Dr University of Iowa Iowa City, IA 52242 (e-mail: Katherine-Mathews@uiowa.edu)
Steven A. Moore, MD, PhD
Iowa City
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
RELATED ARTICLE
Multiminicore Disease in a Family Susceptible to Malignant Hyperthermia: Histology, In Vitro Contracture Tests, and Genetic Characterization
Sandrine Guis, Dominique Figarella-Branger, Nicole Monnier, David Bendahan, Geneviève Kozak-Ribbens, Jean-Pierre Mattei, Joël Lunardi, Patrick J. Cozzone, and Jean-François Pellissier
Arch Neurol. 2004;61(1):106-113.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Congenital Myopathies in Israeli Families
Weiss et al.
J Child Neurol 2007;22:732-736.
ABSTRACT
Central core disease is due to RYR1 mutations in more than 90% of patients
Wu et al.
Brain 2006;129:1470-1480.
ABSTRACT
| FULL TEXT
Malignant Hyperthermia: Update on Susceptibility Testing
Litman and Rosenberg
JAMA 2005;293:2918-2924.
ABSTRACT
| FULL TEXT
|